Matches in Wikidata for { <http://www.wikidata.org/entity/Q60473162> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q60473162 description "im Juli 2005 veröffentlichter wissenschaftlicher Artikel" @default.
- Q60473162 description "wetenschappelijk artikel" @default.
- Q60473162 description "наукова стаття, опублікована в липні 2005" @default.
- Q60473162 name "O-091 A randomized phase II trial of docetaxel alone and in combinationwith gefitinib (IRESSA) as second-line therapy for patients with non-small-cell lung cancer" @default.
- Q60473162 name "O-091 A randomized phase II trial of docetaxel alone and in combinationwith gefitinib" @default.
- Q60473162 type Item @default.
- Q60473162 label "O-091 A randomized phase II trial of docetaxel alone and in combinationwith gefitinib (IRESSA) as second-line therapy for patients with non-small-cell lung cancer" @default.
- Q60473162 label "O-091 A randomized phase II trial of docetaxel alone and in combinationwith gefitinib" @default.
- Q60473162 prefLabel "O-091 A randomized phase II trial of docetaxel alone and in combinationwith gefitinib (IRESSA) as second-line therapy for patients with non-small-cell lung cancer" @default.
- Q60473162 prefLabel "O-091 A randomized phase II trial of docetaxel alone and in combinationwith gefitinib" @default.
- Q60473162 P1433 Q60473162-ED627BE5-6625-46CA-BDCA-CF080A46B46E @default.
- Q60473162 P1476 Q60473162-03175774-75D4-4693-BDBA-6916419E7AD8 @default.
- Q60473162 P2093 Q60473162-1628C43B-C825-4C6F-AF6B-D2757781842F @default.
- Q60473162 P2093 Q60473162-6E1D51FC-7C5E-4DDB-A7ED-9D2BD2558B47 @default.
- Q60473162 P2093 Q60473162-703696D9-2063-481B-9BEC-FC3037C7B232 @default.
- Q60473162 P2093 Q60473162-7F0A37FF-41AA-4EC2-9252-980051C9CBB8 @default.
- Q60473162 P2093 Q60473162-81DFBA5A-483C-4A1F-A387-B043E679EE11 @default.
- Q60473162 P2093 Q60473162-91723145-3CD7-42C7-B710-6D05EE485D8F @default.
- Q60473162 P2093 Q60473162-C440B47F-23CD-4254-8467-5C9A6E1519DA @default.
- Q60473162 P2093 Q60473162-C5E78A44-2A4C-410B-BDEA-C1C183F57B83 @default.
- Q60473162 P2093 Q60473162-D1B420DD-1533-4F8F-8CD5-886557E2E4FC @default.
- Q60473162 P304 Q60473162-18D1882C-F595-48CF-AF8C-904F201A22F8 @default.
- Q60473162 P31 Q60473162-8B452E62-C3DF-4D88-8D6D-F62F90A50AB0 @default.
- Q60473162 P356 Q60473162-3EA28C0B-1AD0-4CE4-9C1D-27E6DDD48552 @default.
- Q60473162 P478 Q60473162-6EAC197C-9ED6-4461-A999-E898D3979D9F @default.
- Q60473162 P50 Q60473162-05AEDDF3-6E85-4C3D-AEE2-D0A292BAEEAD @default.
- Q60473162 P577 Q60473162-BAC55420-4E2C-4EAF-AF55-9FF0CF303E1A @default.
- Q60473162 P921 Q60473162-13CF8E31-D448-4CC9-9161-AB60CF4D8A88 @default.
- Q60473162 P921 Q60473162-F2F8CF87-8129-4303-A3DD-C88555005D19 @default.
- Q60473162 P356 S0169-5002(05)80225-9 @default.
- Q60473162 P1433 Q641464 @default.
- Q60473162 P1476 "O-091 A randomized phase II trial of docetaxel alone and in combinationwith gefitinib (IRESSA) as second-line therapy for patients with non-small-cell lung cancer" @default.
- Q60473162 P2093 "D. Paillotin" @default.
- Q60473162 P2093 "G. Robinet" @default.
- Q60473162 P2093 "I. Monnet" @default.
- Q60473162 P2093 "J. Crequit" @default.
- Q60473162 P2093 "J. Letreut" @default.
- Q60473162 P2093 "L. Falchero" @default.
- Q60473162 P2093 "M. Grivaux" @default.
- Q60473162 P2093 "M. Perol" @default.
- Q60473162 P2093 "P. Thomas" @default.
- Q60473162 P304 "S33" @default.
- Q60473162 P31 Q13442814 @default.
- Q60473162 P356 "10.1016/S0169-5002(05)80225-9" @default.
- Q60473162 P478 "49" @default.
- Q60473162 P50 Q57027992 @default.
- Q60473162 P577 "2005-07-01T00:00:00Z" @default.
- Q60473162 P921 Q420436 @default.
- Q60473162 P921 Q42824440 @default.